世界の患者モニタリングデバイス/装置/システム市場動向（～2018）...市場調査レポートについてご紹介

Table Of Contents

1 Introduction (Page No. – 37)
1.1 Key Take-Aways
1.2 Report Description
1.3 Markets Covered
1.4 Market Scope
1.5 Stakeholders
1.6 Research Methodology
1.6.1 Patient Monitoring Devices Market Size Estimation
1.6.2 Market Crackdown & Data Triangulation
1.6.3 Key Data Points From Primary Sources
1.6.4 Secondary Sources
1.6.5 Patient Monitoring Devices Market Share Analysis
1.6.6 Assumptions

2 Executive Summary (Page No. – 52)

3 Premium Insights (Page No. – 58)
3.1 Patient Monitoring Devices Market Revenue
3.2 Patient Monitoring Devices Market Dynamics
3.3 Product Market Snapshot
3.4 Product Segment Market Snapshot
3.5 Patient Monitoring Devices Market, By Product Segments
3.6 Patient Monitoring Devices Market: Geographic Analysis
3.7 Patient Monitoring Devices Market: End-User Analysis

4 Market Overview (Page No. – 65)
4.1 Introduction of Patient Monitoring Devices
4.2 Patient Monitoring Devices Market Dynamics
4.2.1 Drivers
4.2.1.1 Increasing Geriatric Population to Propel the Need of Monitoring Devices
4.2.1.2 Increasing Incidences of Lifestyle Diseases to Fuel Need of Patient Monitoring Devices
4.2.1.3 Home and Remote Monitoring—An Essential Factor Driving Patient Monitoring Devices Market
4.2.1.4 Ease-of-Use and Portability of Devices to Push Point-of-Care Monitoring Devices
4.2.2 Restraints
4.2.2.1 Economic Downturn and Saturation to Inhibit Growth in Monitoring Devices Market
4.2.2.2 Unstable Reimbursement Regulations to Restrict Growth in Patient Monitoring Devices Market
4.2.3 Opportunities
4.2.3.1 Private Institutional Nursing
4.2.3.2 M&A and Joint Ventures
4.3 Patient Monitoring Devices Market Segmentation
4.4 Patient Monitoring Devices End-User Analysis
4.5 Patient Monitoring Devices Market Share Analysis
4.5.1 Hemodynamic Monitors
4.5.1.1 Blood Pressure Monitors
4.5.1.2 Single Point Blood Glucose Monitors
4.5.1.3 Continuous Blood Glucose Monitors
4.5.1.4 Blood Gas and Electrolyte Analyzers
4.5.2 Neurological Monitors
4.5.2.1 Electroencephalographs (EEG)
4.5.2.2 Transcranial Doppler (TCD)
4.5.2.3 Magnetoencephalographs (MEG)
4.5.2.4 Cerebral Oximetry Monitors
4.5.2.5 Intracranial Pressure (Icp) Monitors (Top Players)
4.5.3 Cardiac Monitors
4.5.3.1 Electrocardiographs (ECG)
4.5.3.2 Event Monitors
4.5.3.3 Cardiac Output Monitors
4.5.4 Respiratory Monitoring Devices
4.5.4.1 Capnographs
4.5.4.2 Spirometers
4.5.4.3 Anesthesia Monitors
4.5.4.4 Sleep Apnea Monitors
4.5.4.5 Pulse Oximeters
4.5.5 Fetal & Neonatal Monitors
4.5.6 Multi-Parameter Monitors

5 Hemodynamic Monitoring Devices (Page No. – 94)
5.1 Introduction
5.2 Drivers & Opportunities
5.2.1 Increase in the Number of Hypertension Cases
5.2.2 Increase in Diabetic Population
5.2.3 Increasing Use of Non-Invasive Devices to Boost the Market Growth
5.2.4 Increasing Population Opting for Self-Monitoring Devices
5.3 Restraint
5.3.1 Highly Fragmented Hemodynamic Monitoring Devices Market
5.4 Blood Pressure Monitoring Devices
5.5 Blood Glucose Monitoring Devices
5.5.1 Market Dynamics
5.5.1.1 Advancing Technology
5.5.1.2 Large Population of Undiagnosed Diabetics Poses A Growth Opportunity for New Entrants
5.5.1.3 Decreasing Price of Blood Glucose Kits to Reduce Market Size & Restrain Growth
5.6 Blood Gas & Electrolyte Analyzers/Monitors
5.6.1 Drivers & Restraints
5.6.1.1 Inadequacy of Alternate Techniques Provides Stable Growth for Invasive Blood Gas and Electrolyte Analyzers
5.6.1.2 Complex Operation & Interpretation Restricts the Use of These Devices & Reduces Growth of the Market
5.7 Cholesterol Monitoring Devices

6 Neuromonitoring Devices (Page No. – 126)
6.1 Introduction
6.2 Drivers
6.2.1 Increasing Incidences of Neurodegenerative Diseases, A Major Driver for Neuromonitoring Devices
6.2.2 Rising Awareness & Exposure to Literature About Neurodegenerative Diseases
6.2.3 Advanced Technology
6.2.4 Monitoring for Invalids & Infants to Drive Neuromonitoring Research
6.3 Restraints
6.3.1 Difficulty in Early Detection
6.3.2 Complex Interpretation Restricts the Use of These Devices
6.4 Opportunities
6.4.1 Telemetric Neuromonitoring Shows Advanced Options in Neuromonitoring
6.5 Electroencephalograph (EEG)
6.6 Transcranial Doppler (TCD)
6.7 Magnetoencephalograph (MEG)
6.8 Cerebral Oximeters
6.9 Intracranial Pressure Monitors (Icp)

7 Cardiac Monitoring Devices (Page No. – 151)
7.1 Introduction
7.2 Drivers & Opportunities
7.2.1 Increasing Incidences of Cardiovascular Diseases, A Primary Driver
7.2.2 Rise In Cost of Heart Disease Treatment Will Drive the Market Growth for Monitoring
7.2.3 ECG Data Management Systems, A Rising Opportunity
7.3 ECG Devices
7.3.1 Market Dynamics
7.3.1.1 Increasing Incidence of Cvd to Boost the Growth of ECG Monitors
7.3.1.2 Technological Advancements to Drive the Growth of ECG Telemetry Devices
7.3.1.3 Asian Region is Providing Significant Growth Prospects
7.3.1.4 Market Maturity to Restrict the Growth
7.4 Cardiac Output Monitoring Devices
7.5 Event Monitors
7.5.1 Outsourcing to Event Monitoring Centers, A Key Growth Factor

8 Fetal & Neonatal Monitoring Devices (Page No. – 174)
8.1 Introduction
8.2 Drivers & Opportunities
8.2.1 High Number of Preterm Births
8.2.2 Birth Rates & Natality
8.2.3 Increasing Access to Pregnancy Information
8.2.4 Price Cuts & Advancements in Technology Resulting in Increased Use of Fetal & Neonatal Monitors
8.2.5 Portable & Wireless Doppler
8.3 Restraints
8.3.1 Government Regulations Restrict Sale of Fetal Monitoring Devices

9 Respiratory Monitoring Devices (Page No. – 186)
9.1 Introduction
9.2 Drivers
9.2.1 Rising Focus on Monitoring Respiratory Diseases
9.2.2 Increasing Incidences of Respiratory Diseases
9.2.3 Regulations to Monitor Patients’ Respiratory Status
9.2.4 Pollution, Habitual Smoking Has Increased the Demand for Respiratory Monitoring Devices
9.3 Capnographs
9.3.1 Market Dynamics
9.3.1.1 Alternate Uses of Capnography are Boosting the Market Growth
9.3.1.2 Market Consolidation to Slow the Growth
9.4 Spirometer Devices
9.5 Anesthesia Monitors
9.6 Sleep Apnea Monitoring Devices
9.6.1 Driver
9.6.1.1 Increasing Incidence of Obstructive Sleep Apnea (Osa)
9.7 Pulse Oximeters
9.7.1 Driver & Restraint
9.7.1.1 Adoption of New Technologies & Increase in Awareness Levels to Propel the Market Growth
9.7.1.2 Multi-Parameter Integration to Restrain Stand-Alone Devices Market

10 Multi-Parameter Monitoring Devices (Page No. – 220)
10.1 Introduction
10.2 Drivers & Opportunities
10.2.1 Increasing Number of Hospitalizations to Drive the Market
10.2.2 Remote Monitoring & Home Monitoring to Drive Mid-Acuity and Low-Acuity Segments

11 Remote Patient Monitoring Devices Market (Page No. – 233)
11.1 Introduction of Remote Patient Monitoring Devices Market
11.2 Drivers & Restraints
11.2.1 Government Regulations to Curb Healthcare Costs
11.2.2 Aging Population
11.2.3 Technological Advances
11.2.4 Healthcare Consumerism Pattern
11.2.5 Cost of Remote Patient Monitoring Devices, A Restraint 236
11.3 Opportunities
11.3.1 Nascent Stage of Market
11.3.2 Mergers, Acquisitions, Joint Ventures, & Collaborations Pose As Opportunities

12 Weight Monitoring Devices (Page No. – 239)
12.1 Introduction
12.1.1 Market Dynamics
12.1.1.1 Rising Prevalence of Obesity is the Major Factor for Growth
12.1.1.2 Highly Saturated & Matured Market Reduces the Scope for Growth & Profit

13 Temperature Monitoring Devices (Page No. – 246)
13.1 Introduction
13.1.1 Drivers
13.1.1.1 Growth in the Number of Health Conscious Consumers Driving the Market Growth
13.1.1.2 Technological Innovations to Boost the Market Growth

14 Geographic Analysis (Page No. – 254)
14.1 Introduction
14.2 North America
14.3 Europe
14.4 Asia-Pacific
14.5 Rest of the World (ROW)

15 Competitive Landscape (Page No. – 290)
15.1 Introduction
15.2 New Product Launches
15.3 Mergers & Acquisitions
15.4 Agreements/Partnerships/Collaborations
15.5 Expansions
15.6 Other Developments

16 Company Profiles (Overview, Products & Services, Financials, Strategy, & Developments)* (Page No. – 328)
16.1 A&D Medical Company Ltd.
16.2 Abbott Laboratories
16.3 AMBU Inc.
16.4 Briggs Healthcare
16.5 Cardiocom (Medtronic)
16.6 Cardionet, Inc. (Biotelemetry, Inc.)
16.7 Carefusion Corporation
16.8 Compumedics Limited
16.9 Conmed
16.10 Contec Medical Systems Co. Ltd.
16.11 Covidien
16.12 Drager Medical Gmbh
16.13 Edwards Lifesciences Corporation
16.14 Elekta AB
16.15 Fukuda Denshi Company Ltd.
16.16 Ge Healthcare
16.17 Honeywell International Inc.
16.18 Intouch Health
16.19 Johnson & Johnson, Inc.
16.2 Lifewatch AG
16.21 Masimo Corporation
16.22 Mindray Medical International Limited
16.23 Mortara Instrument, Inc.
16.24 Natus
16.25 Nihon Kohden
16.26 Nonin Medical Inc.
16.27 Omron
16.28 OSI Systems Inc. (Spacelabs Healthcare)
16.29 Robert Bosch Healthcare Inc.
16.3 Roche Diagnostics Limited
16.31 Royal Philips Healthcare
16.32 Schiller AG
16.33 Seca Gmbh & Co. Kg.
16.34 Siemens Healthcare
16.35 Smiths Medical
16.36 Welch Allyn
16.37 Yokogawa Electric Corporation

*Details on Overview, Products & Services, Financials, Strategy, & Developments Might Not Be Captured in Case of Unlisted Companies.